MLTX Earnings
Monday, May 11 2026
EPS Estimate
$-0.89
$-1.01 – $-0.81
Current Price
$17.22
Our Position
bearishGoldman Raises Target But Keeps Sell on Approval Risk
structured data
est. revisions rising
(+4.2pp / 30d)
Clinical efficacy ≠ approval certainty. The market's already pricing in a significant approval discount — Goldman's target adjustment suggests the stock trades below intrinsic value IF sonelokimab clears the FDA, but the analyst isn't betting on that outcome. This is a high-risk clinical-stage bet where optionality matters more than current valuation.
Watch: FDA feedback on sonelokimab's regulatory pathway and timeline. A guidance meeting or positive breakthrough designation could rewire Goldman's Sell thesis; silence or negative feedback would validate the skepticism baked into current risk-reward.
Data Signal Summary
2 bullish
2 bearish
Estimates up +4%
Insider selling cluster
Put/call 0.4 (bullish skew)
Price downtrend
Key Context
Insider Activity
selling
Price Trend
downtrend
From 52w High
-11.3%
Est. Revisions (30d)
+3.6% 2up/0dn
Analyst Target (mean)
$27 $6–$40 +55%
Options P/C Ratio
0.43
Est. Dispersion
22% 8 analysts
Insider Cluster
strong sell (officer)
Fund Convergence
strong Citadel, Renaissance, Two Sigma
Recent Activity
insider trades
20 transactions
Sell
·
BODENSTEDT MATTHIAS (Chief Financial Officer)
·87,795 shares
·$1,663,935
Sell
·
BVF PARTNERS L P (Beneficial Owner of more than 10% of a Class of Security)
·3,750,000 shares
·$62,962,500
Award
·
BODENSTEDT MATTHIAS (Chief Financial Officer)
·354,296 shares
Other
·
SANTOS DA SILVA JORGE (Chief Executive Officer)
·196,316 shares
Other
·
BODENSTEDT MATTHIAS (Chief Financial Officer)
·294,473 shares
15 more
Other
·
REICH KRISTIAN
·35,389 shr
Sell
·
SANTOS DA SILVA JORGE
·200,000 shr
·$2,974,700
Sell
·
REICH KRISTIAN
·202,908 shr
·$3,012,462
Buy
·
BODENSTEDT MATTHIAS
·10,870 shr
·$98,808
Sell
·
CHEN BIHUA X.
·6,499,978 shr
·$41,618,529
Other
·
REICH KRISTIAN
·48,978 shr
Sell
·
MOUKHEIBIR CATHERINE
·23,500 shr
·$1,146,565
Other
·
MOUKHEIBIR CATHERINE
·23,500 shr
Award
·
SANTOS DA SILVA JORGE
·95,763 shr
Award
·
BODENSTEDT MATTHIAS
·95,763 shr
Other
·
REICH KRISTIAN
·111,949 shr
Sell
·
BVF PARTNERS L P
·2,000,000 shr
·$100,003,200
Sell
·
STURGE SIMON J
·171,000 shr
·$9,186,120
Sell
·
SANTOS DA SILVA JORGE
·150,000 shr
·$2,752,163
Sell
·
BODENSTEDT MATTHIAS
·2,426 shr
·$47,453
Explore more
